ArticleOncoTargets and therapy2017

Tbx2 confers poor prognosis in glioblastoma and promotes temozolomide resistance with change of mitochondrial dynamics.

Fuxin Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.